nach oben

BMC Pediatrics

Erschienen in:

Open Access 01.12.2023 | Research

The effect of zinc supplementation on anthropometric measurements in healthy children over two years: a systematic review and meta-analysis

verfasst von: Vahid Monfared, Adel Salehian, Zeinab Nikniaz, Soraiya Ebrahimpour-Koujan, Zeinab Faghfoori

Erschienen in: BMC Pediatrics | Ausgabe 1/2023

Abstract

Background

Zinc deficiency is one of the most important micronutrient deficiencies in children that can affect the children’s growth pattern. In this regard, different studies were conducted to assess the effect of zinc supplementation on growth patterns in healthy children. To the best of our knowledge, no systematic review has summarized the results of these studies. So, in the present study, we systematically reviewed the result of the studies that assessed the effect of zinc supplementation on anthropometric parameters in healthy, over 2-year-old children.

Methods

A systematic search was carried out in PubMed, Scopus, and Web of Science from inception to November 2021. Data were pooled using the random-effects method and were expressed as weighted mean difference (WMD) and 95% confidence intervals (CI).

Results

The pooled results of eight studies, including 1586 participants, showed that zinc supplementation significantly increases height [(WMD): 0.9, 95% CI: (0.27, 1.52), p < 0.001], weight [(WMD): 0.51, 95% CI: (0.06, 0.97), p < 0.001], height for age (HAZ) [(WMD): 0.07, 95% CI: (0.03, 0.10), p < 0.001]. Also, meta-regression analysis did not reveal any significant association between dose and duration of intervention and anthropometric parameters.

Conclusion

The present study demonstrates the beneficial effects of zinc supplementation on weight, height, and HAZ.

Supplementary Material 1

Supplementary Material 2

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12887-023-04249-x.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Child growth is a vital indicator of health status in the human life cycle. Different factors including childhood infections, child undernutrition, and food insecurity could affect the child’s growth [1]. Child undernutrition is the underlying cause of three million annual deaths worldwide [2]. It includes stunting, wasting, and essential micronutrient deficiencies. Failure to properly treat nutritional deficiencies, or even subclinical malnutrition, can have detrimental effects on an individual’s health and the nation’s overall economic growth [3].

One of the most important micronutrient deficiencies especially in children is attributed to zinc deficiency [4]. Zinc insufficiency is a huge issue in terms of public health that affects over two billion people all over the world [5, 6]. In Iran, it has been estimated that 10% of people suffer from zinc deficiency [7, 8]. It has been demonstrated that zinc deficiencies cause children to have slower rates of growth. This issue seems more important in children over two years. Because in children under two years of age, maternal breastfeeding, could provide the children`s need for zinc [9]. In addition, the body store of zinc from in-utero development could partly compensate for the body’s need for zinc [10].

In this context, the World Health Organization (WHO) and the United Nations Children’s Fund are presently advocating for the use of a micronutrient powder formulation that contains 4.1-5 mg of zinc together with 14 other micronutrients [11]. In terms of zinc supplementation, some meta-analysis studies were conducted to assess its effect on the growth of children. Brown et al., systematically reviewed the effect of zinc supplementation in prepubertal children [12]. Imdad et al. assessed the effect of zinc supplementation on the growth pattern of under five-year-old children in developing countries [13]. Liu et al. reviewed the effect of zinc supplementation in children with growth retardation. Different original publications also assessed the effect of zinc supplementation on the growth pattern of healthy children and provided mixed results. To the best of our knowledge, there is no systematic review study that summarizes the result of these studies. So, the current meta-analysis was carried out to compile a summary of the evidence that is currently available on the influence of zinc supplementation on anthropometric parameters in healthy children.

Materials and methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) procedure served as the basis for the planning, execution, and reporting of this work [14].

Search strategy

Online databases including Scopus, Web of Science, and PubMed were searched to find all the relevant clinical trials up to November 2021. The search strategy for each database is provided in Table S1. The following search terms were used: Population: children; Intervention: Zinc, outcome: Anthropometric Measurements. In addition, we conducted a hand search of the reference lists of the relevant papers and review papers to include any other studies that might be suitable.

Inclusion criteria

Clinical trials were included in the present systematic review and meta-analysis if they fulfilled the following inclusion criteria: (a) were randomized with either parallel or crossover designs in healthy children over 2 years; (b) reported anthropometric indices before and after intervention in each group; (c) compared zinc supplementation with the placebo. Studies were excluded if they: (a) do not use zinc alone; (b) did not provide effects sizes on anthropometric factors before and after the trial; (c): Abstracts, conference proceedings or book chapters, and unpublished studies.

Two investigators (ED and FA) selected eligible articles separately by reading titles, abstracts, and whenever required the full text of the publications. Any disagreements in this regard were resolved through discussion with the third researcher (ZF).

Data extraction

Data extraction was done by two researchers independently (VM and AS). The disagreements were settled through discussion and by agreeing with the assistance of a third reviewer (ZN). The following information was extracted: name of the first author, publication year, individuals’ characteristics (mean age), study design, sample size, type of zinc prescribed, the dosage of zinc, unit, and duration of intervention. The corrected mean changes and standard deviations of anthropometric measurements were taken during the study for both the intervention group and the control group, as well as the variables that were considered to be confounding.

Risk of bias assessment

The Cochrane quality assessment tool was used for assessing the risk of bias [15]. Two reviewers independently assessed the risk of bias (VM and AS) and the risk of bias was divided into high risk, low risk, and unclear risk.

Certainty assessment

The overall certainty of evidence across the studies was graded according to the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) guideline, and the evidence was divided into high, moderate, low, and extremely low categories [16].

Statistical analysis

The overall effect sizes were calculated using the mean changes in anthropometric measurements and their respective standard deviations (SD). In studies that reported the SEM, the SD was determined using the following formula: SD = SEM × √n, in which the n is the sample size. The I² statistic and Cochrane’s Q test were used to determine the presence of heterogeneity. Significant heterogeneity was determined if the I² value was > 50% or P < 0.05 [17]. To find probable sources of heterogeneity, subgroup analyses were performed according to the predefined variables including gender, country region (Asian or Non-Asian), sample size, and duration of studies (> 24,<24). A sensitivity analysis was performed to determine whether or not the overall effect size was dependent on a specific study. The formal test developed by Begg and Egger looked into the possibility of publication bias. Stata, version 14 was utilized for the meta-analysis, and a P-value < 0.05 was considered a significant level.

Results

Study selection

As shown in Fig. 1, of 9939 publications that were retrieved in a systematic search, 25 articles remained for full-text evaluation. Additional 17 articles were excluded by full text for the following reasons: not being clinical trials [18‐20], do not use zinc alone [21‐25], non-healthy subjects [26‐28], under 2 years [29‐33], and zinc supplementation of mothers [34]. Finally, eight eligible RCTs remained for inclusion in the current systematic review and meta-analysis [35‐42].

Study characteristics

The characteristics of included RCTs are illustrated in Table 1. Two studies were performed on boys and two on girls and four on both genders. The sample size of included RCTs varied from 46 to 804 participants, resulting in a total sample size of 1586. The dosage of zinc supplements varied from 5 to 15 mg/day, and the duration of intervention ranged from 6 to 28 weeks.

Table 1

Characteristic of included studies in meta-analysis

studies	Study Design	Country	Sample size	Sample size		Trial Duration (Week)	Means Age(month)		Intervention		dose 15 mg/day
studies	Study Design	Country	Sample size	IG	CG	Trial Duration (Week)	IG	CG	zinc	Control group	dose 15 mg/day
Ruz et al. 1997	RCT	USA	98	49	49	56	39/8	39/8	Zinc	placebo	10 mg/day
Kikafunda et al. 1998	RCT	Ugandan	153	78	75	32	55/5	56/1	Zinc sulfate	placebo	10 mg/day
Clark et al. 1999	RCT	Netherland	46	25	21	6	NR	NR	Zinc	placebo	15 mg/day
Ebrahimi et al. 2006	RCT	Iran/Yasuj	804	386	418	28	NR	NR	Zinc syrup	placebo	10 mg/day
Dehbozorgi et al. 2007	RCT	Iran/Shiraz	60	30	30	24	NR	NR	Zinc sulfate	placebo	8 mg/day
Kaseb et al. 2013	RCT	Iran/Yasuj	95	48	47	16	143/16	148/92	Zinc sulfate	placebo	5 mg/day
Vakili/girl et al.2015	RCT	Iran/Mashhad	100	50	50	24	94/5	95/64	Zinc sulfate	placebo	10 mg/day
Vakili/boy et al.2015	RCT	Iran/Mashhad	100	50	50	24	91/78	91/84	Zinc sulfate	placebo	10 mg/day
Sanguansak et al.2017	RCT	Thailand	130	66	64	24	106/8	105/6	Zinc bisglycinate	placebo	15 mg/day

Abbreviations: IG: intervention group; CG: control group; NR: not reported

Risk of bias result

The result of the risk of bias is shown in Table 2. Only two studies [36, 37] could be considered high-quality studies, two RCTs [42, 43] were of moderate quality and others had low-quality.

Table 2

Risk of bias assessment for randomized clinical trials included in the current meta-analysis on the effect of zinc supplementation on Anthropometric factors in Healthy children over 2 years¹

studies	Selection bias (random sequence generation)	Selection bias (allocation concealment)	Performance bias	Attrition bias	Detection bias	Reporting bias	Other sources of bias
Sedigheh ebrahimi et al. 2006	L	U	L	U	U	H	U
Joyce K Kikafunda et al. 1998	L	H	L	L	L	L	L
Peter J Clark et al. 1999	L	H	L	U	L	L	L
Sanguansak Rerksuppaphol et al. 2017	L	L	L	L	L	L	L
Manuel ruz et al. 1997	L	L	L	L	L	L	L
Rahim Vakili et al. 2015	L	U	L	L	L	L	L
Fatemeh Kaseb et al. 2013	L	L	H	L	H	L	L
P.dehbozorgi 2007	L	L	L	L	U	L	L

L: low risk H: high risk U: unclear

¹Each study was assessed for risk of bias using the Cochrane Risk of Bias Assessment tool. Each domain was scored as “high risk” if it contained methodological flaws that may have affected the results, “low risk” if the flaw was deemed inconsequential, and “unclear risk” if information was insufficient to determine. If a study got “low risk” for all domains, it considered as a high-quality study with totally low risk of bias

Grading of evidence

The GRADE protocol was used to assess the certainty of the evidence (Table 3). Accordingly, studies investigating the effects of zinc supplementation on weight and height were regarded as moderate quality due to the high heterogeneity between studies. Moreover, the effects of zinc supplementation on HAZ, and WAZ had moderate quality evidence. HAZ had low heterogeneity and WAZ has high heterogeneity.

Table 3

GRADE profile of the effect of zinc supplementation on Anthropometric factors in Healthy children over 2 years

Quality assessment						Summary of findings		Quality of evidence
Outcomes	Risk of bias	Inconsistency	Indirectness	Imprecision	Publication Bias	Number of intervention / control	WMD (95%CI)	Quality of evidence
weight	No serious limitations	Very Serious limitations ^a	No serious limitations	No serious limitations	No serious limitations	733/755	0.9 (0.27,1.52)	⊕⊕⊕◯ Moderate
height	No serious limitations	Very serious ^b limitations	No serious limitations	No serious limitations	No serious limitations	733/755	0.51 (0.06,0.97)	⊕⊕⊕◯ Moderate
WAZ	No serious limitations	serious limitations ^c	No serious limitations	No serious limitations	No serious limitations	293/288	0.06 (-0.03,0.15)	⊕⊕⊕◯ Moderate
HAZ	No serious limitations	No serious limitations ^d	No serious limitations	serious limitations	No serious limitations	293/288	0.07 (0.03,0.10)	⊕⊕⊕◯ Moderate

^{WAZ: weight for age; HAZ: height for age}

^a The test for heterogeneity is significant, and the I² is high, 93.9%

^b The test for heterogeneity is significant, and the I² is high, 95.9%

^c The test for heterogeneity is significant, and the I² is moderate, 72.4%

^d The test for heterogeneity is not significant, and the I² is low, 33.1%

Findings from the meta-analysis

Overall, eight RCTs were included in the meta-analysis. These trials had a total sample size of 1586 individuals aged two years and over.

The effect of zinc supplementation on weight

The effects of zinc supplementation on weight were evaluated in seven research, including 1488 people [35, 36, 38‐42]. Considering the presence of high heterogeneity between studies (I² = 95.9, P < 0.001), the random-effect model was used. The result indicated that zinc supplementation had a significant impact on weight [(WMD): 0.51, 95% CI: (0.06, 0.97), p < 0.001] (Fig. 2-B). The heterogeneity might be explained by the location of the study, duration of intervention, gender, and sample size. The subgroup analysis showed that the studies conducted in Asian countries (I² = 0.0%, p = 0.545) and gender (boy, I² = 40.4 p = 0.195) were the potential sources of heterogeneity (Table 4).

Table 4

Subgroup analyses the effect of zinc supplementation on Anthropometric factors in Healthy children over 2 years

	Number of studies	WMD (95% CI)	I² (%)	P-between	P for heterogeneity
The effect of zinc supplementation on height
Location
Asian	2	0.13 (0.10, 0.16)	91.6	< 0.001	0.001
Non-Asian	6	0.99 (0.77, 1.22)	88.9		< 0.001
Sample size				< 0.001
≥ 100	5	0.77 (0.55, 0.99)	94.9		< 0.001
< 100	3	0.13 (0.10, 0.16)	60.1		0.081
gender				< 0.001
Girl	2	0.09 (-0.24, 0.42)	93.4		< 0.001
Boy	2	1.20 (0.08, 1.53)	96.6		< 0.001
both	4	0.13 (0.10, 0.17)	89.4		< 0.001
Duration (weeks)				< 0.001
24<	2	0.13 (0.01, 0.16)	0		0.975
24≥	6	0.78 (0.57, 0.99)	93.6		< 0.001
The effect of zinc supplementation on weight
location
Asian	2	0.12 (0.10, 0.14)	0	< 0.001	0.545
Non-Asian	6	0.95 (0.82, 1.08)	74		< 0.001
Sample size				< 0.001
≥ 100	5	0.73 (0.50, 0.95)	70.8		0.008
< 100	3	0.14 (0.12,0.16)	98.4		< 0.001
gender				< 0.001
Girl	2	0.93 (0.63, 1.22)	83.3		0.015
Boy	2	0.33 (-0.06, 0.72)	40.4		0.195
both	4	0.14 (0.12, 0.16)	97.7		< 0.001
duration				< 0.001
24<	2	0.14 (0.12, 0.16)	99.2		< 0.001
24≥	6	0.68 (0.46, 0.89)	49		0.007
The effect of zinc supplementation on WAZ
location				0.09
Asian	2	0.02 (0.00, 0.03)	0		0.588
Non-Asian	3	0.08 (0.01, 0.15)	82.4		0.003
Sample size				0.002
≥ 100	3	0.16 (0.07, 0.25)	48.9		0.141
< 100	2	0.02 (0.00, 0.03)	22.3		0.257
gender				0.002
Girl	1	0.23 (0.10, 0.35)
Boy	1	0.14 (-0.02, 0.30)
both	3	0.02 (00.0, 0.03)	0		0.456
duration				0.009
24<	2	0.02 (0.00, 0.03)	0		0.05
24≥	3	0.08 (0.01, 0.15)	82.4		0.003
The effect of zinc supplementation on HAZ
location
Asian	2	0.05 (0.04, 0.06)	0	0.004	0.607
Non-Asian	3	0.10 (0.05, 0.15)	0		0.399
Sample size				0.050
≥ 100	3	0.10 (0.05, 0.15)	0		0.403
< 100	2	0.05 (0.04, 0.06)	0		0.562
gender				0.006
Girl	1	0.04 (0.06, 0.15)
Boy	1	0.13 (0.06, 0.19)
both	3	0.05 (0.04, 0.06)	0		0.742
duration				0.04
24<	2	0.05 (0.04, 0.06)	0		0.607
24≥	3	0.10 (0.05, 0.15)	0		0.399

The effect of zinc supplementation on height

The effects of zinc supplementation on height were evaluated in seven research, including 1488 people [35, 36, 38‐42]. Considering the presence of high heterogeneity (I² = 93.9, P < 0.001), the random effect model was used. The result showed that zinc supplementation had a significant effect on height [(WMD): 0.9, 95% CI: (0.27,1.52), p < 0.001] (Fig. 2-A). As shown in Table 4, the heterogeneity might be explained by the location of the study, duration of intervention, gender, and sample size. The subgroup analysis showed that the intervention duration of ≥ 24 weeks (I² = 0.0%, p = 0.975) was the potential source of heterogeneity. An intervention duration of greater than 24 weeks (WMD 0.78; 95% CI: 0.57 to 0.99, p < 0.000) significantly increased height compared with a shorter intervention duration (WMD: 0.13; 95% CI: 0.10 to 0.16, p = 0.975). Moreover, we found a significant increase in height with zinc supplementation in RCTs with a sample size of less than 100 (Table 4).

The effect of zinc supplementation on WAZ

The effects of zinc supplementation on WAZ were evaluated in four studies (with five effect sizes), including 581 subjects [35‐37, 40]. There was high heterogeneity between studies (I² = 72.4, P = 0.006). The result of the random-effect model showed that zinc supplementation had a significant impact on WAZ [(WMD): 0.06, 95% CI: (-0.03, 0.15), p-value = 0.18] (Fig. 2-C). The heterogeneity might be explained by the duration of the intervention, gender, and sample size. The subgroup analysis showed that all subgroups were the potential sources of heterogeneity and we found a significant increase in WAZ with zinc supplementation with duration 24≥, and among non-Asian people (Table 4).

The effect of zinc supplementation on HAZ

The effects of zinc supplementation on HAZ were evaluated in four research (with five effect sizes), including 581 people [35‐37, 40]. There was no significant between-study heterogeneity (I² = 33.1, P = 0.20). The result of the fixed-effect model indicated that zinc supplementation had no significant impact on HAZ [(WMD): 0.07, 95% CI: (0.03, 0.10), p < 0.001] (Fig. 2-D).

Sensitivity analysis

The results of the sensitivity analysis revealed that the magnitude of the overall effect regarding the association between zinc supplementation and height, WAZ, and HAZ did not depend on a single study. However, in terms of weight, the total impact size depended on some studies [35‐42]. As a result, when those studies were disregarded, a substantial positive correlation between zinc supplementation and weight was discovered.

Publication bias

As can be seen on the funnel plot (Figure S1 A-D), there were no signs of publication bias in the studies that evaluated the effect of zinc supplementation on weight, height, WAZ, and HAZ.

Meta-regression analysis

Meta-regression was used to investigate the potential linear association between dose and duration of intervention, with absolute changes in anthropometric indices. Accordingly, meta-regression analysis did not reveal any significant association between the dose of supplementation with weight changes (p_{linearity = 0.54}), height (p_{linearity = 0.09}), HAZ (p_{linearity = 0.89}), WAZ (p_{linearity = 0.43}) (Figure S2 A-D). Likewise, there was no significant association between the duration of intervention with weight changes (p_{linearity = 0.92}), height (p_{linearity = 0.51}), WAZ (p_{linearity = 0.96}), HAZ (p_{linearity = 0.31}) (Figure S3 A-D).

Discussion

Child malnutrition is one of the main public health challenges worldwide and about 45% of under 5-year-old children’s death is attributed to undernutrition [44]. In this regard, zinc deficiency is considered one of the most important causes of morbidity [45]. So, different studies were conducted to assess the effect of zinc supplementation on child growth in healthy children over two years of age. The meta-analysis of these studies showed that zinc supplementation had a significant effect on healthy children’s weight and height. Previous meta-analysis in prepubertal children showed a significant, positive effect of zinc supplementation on height and weight [12]. In under-five-year-old children in developing countries, Imdad et al. demonstrated the significant effect of zinc supplementation on linear growth [13]. In children with growth retardation, Liu et al. showed a significant effect of zinc supplementation on height, and weight [10]. However, Ramakrishnan et al. did not show a positive effect of zinc supplementation on weight and height in under five-year-old children [46]. The differences between the results of the various meta-analysis may be partly related to the differences in the age group of children. It has been shown that zinc supplementation had a more positive effect on over two years of old children compared with infant. Moreover, the health status of children can affect the result. For example, Liu et al. conducted a meta-analysis study on children with growth retardation. However, in the present meta-analysis, we included the paper with healthy subjects.

The positive effect of zinc supplementation on weight and height may be related to the effect of zinc on the metabolism of growth hormones (GH). Zinc had a positive effect on the secretion and sensitivity of GH [47‐49]. Moreover, zinc had an important role in the binding of GH to its receptors [50]. In addition, zinc regulates the expression of GH receptor and insulin-like growth factor 1 (IGF1) genes in the liver [51]. Besides, zinc supplementation increases the insulin-like growth factor-1, and insulin-like growth factor binding protein-3 in healthy children [52].

In the present study, we indicated the significant effect of zinc supplementation on HAZ but not WAZ of healthy children over two-year-old. Conversely, Liu et al. reported the significant effect of zinc supplementation on WAZ in children over two years. In the present systematic review, we included studies with healthy participants, however, Liu et al. conducted a systematic review on studies with children with retarded growth.

In subgroup analyses, we found that intervention duration, study location, gender, and sample size were significant sources of heterogeneity. A previous meta-analysis study indicated that a longer dose of zinc intervention resulted in a more effect on the risk factors [53]. In addition, gender differences have been observed in the association of zinc and other diseases [54]. Moreover, the higher prevalence of zinc deficiency in developing countries may justify the effect of study location on heterogeneity [55]. Besides, a previous study showed that studies with small sample sizes are more heterogeneous than large ones [56].

Limitations

In the current meta-analysis, some potential limitations should be addressed. The publication bias could not be fully excluded. There was considerable heterogeneity between the included studies. Although we performed a subgroup meta-analysis for some factors, not all sources of statistical heterogeneity were recognized. In addition, not all included studies are methodologically sound. The potential methodological problems of studies were as follow selection bias, performance bias, detection bias, and reporting bias.

Conclusion

Altogether, the results of this meta-analysis are in favor of the effect of zinc supplementation on weight, WAZ, and height in healthy under-two-year-old children. Considering the limitations of the included studies, these findings should be confirmed by more high-quality randomized clinical trials that focus on the long-term effects of zinc supplementation on anthropometric indices.

Acknowledgements

The authors wish to thank Semnan University of Medical Sciences, Semnan, Iran for support.

Declarations

This systematic and meta-analysis study was approved by the ethical committee of Semnan University of Medical Sciences, Semnan, Iran (reference number IR.SEMUMS.REC.1401.013).

Not applicable.

Competing interests

The authors declare no competing interests.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Bekele T, Rawstorne P, Rahman B. Trends in child growth failure among children under five years of age in Ethiopia: evidence from the 2000 to 2016 demographic and health surveys. PLoS ONE. 2021;16(8):e0254768.PubMedPubMedCentral

Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, De Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R. Maternal and child undernutrition and overweight in low-income and middle-income countries. The lancet. 2013;382(9890):427–51.

Sazawal S, Habib AA, Dhingra U, Dutta A, Dhingra P, Sarkar A, Deb S, Alam J, Husna A, Black RE. Impact of micronutrient fortification of yoghurt on micronutrient status markers and growth–a randomized double blind controlled trial among school children in Bangladesh. BMC Public Health. 2013;13(1):1–11.

Hassanein M, Zaki NM, Ahmed AG. Effect of Zn foliar application on growth and yield characteristics of two wheat cultivars. Curr Sci Int. 2019;8(3):491–8.

Organization WH. The world health report 2000: health systems: improving performance. World Health Organization; 2000.

Diab L, Krebs NF. Vitamin excess and Deficiency. Pediatr Rev. 2018;39(4):161–79.PubMed

Gupta S, Brazier AKM, Lowe NM. Zinc deficiency in low- and middle-income countries: prevalence and approaches for mitigation. J Hum Nutr Diet. 2020;33(5):624–43.PubMed

Gonoodi K, Moslem A, Darroudi S, Ahmadnezhad M, Mazloum Z, Tayefi M, Zadeh SAT, Eslami S, Shafiee M, Khashayarmanesh Z, et al. Serum and dietary zinc and copper in iranian girls. Clin Biochem. 2018;54:25–31.PubMed

Brown KH, Engle-Stone R, Krebs NF, Peerson JM. Dietary intervention strategies to enhance zinc nutrition: promotion and support of breastfeeding for infants and young children. FoodNutr Bull. 2009;30(1suppl1):144–S171.

10.

Liu E, Pimpin L, Shulkin M, Kranz S, Duggan CP, Mozaffarian D, Fawzi WW. Effect of zinc supplementation on growth outcomes in children under 5 years of age. Nutrients. 2018;10(3):377.PubMedPubMedCentral

11.

Jefferds ME, Irizarry L, Timmer A, Tripp K. UNICEF—CDC global assessment of home fortification interventions 2011: current status, new directions, and implications for policy and programmatic guidance. FoodNutr Bull. 2013;34(4):434–43.

12.

Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2002;75(6):1062–71.PubMed

13.

Imdad A, Bhutta ZA. Effect of preventive zinc supplementation on linear growth in children under 5 years of age in developing countries: a meta-analysis of studies for input to the lives saved tool. BMC Public Health. 2011;11(3):22.

14.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021, 372.

15.

Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentral

16.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedPubMedCentral

17.

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMed

18.

Black RE, Fischer Walker C. Role of zinc in child health and survival. Nestle Nutr Inst Workshop Ser. 2012;70:37–42.PubMed

19.

Gunanti IR, Al-Mamun A, Schubert L, Long KZ. The effect of zinc supplementation on body composition and hormone levels related to adiposity among children: a systematic review. Public Health Nutr. 2016;19(16):2924–39.PubMedPubMedCentral

20.

Yakoob MY, Lo CW. Nutrition (micronutrients) in child growth and development: a systematic review on current evidence, recommendations and opportunities for further research. J Dev Behav Pediatr. 2017;38(8):665–79.PubMed

21.

Nenni V, Nataprawira HM, Yuniati T. Role of combined zinc, vitamin A, and fish oil supplementation in childhood tuberculosis. Southeast Asian J Trop Med Public Health. 2013;44(5):854–61.PubMed

22.

Prawirohartono EP, Nyström L, Ivarsson A, Stenlund H, Lind T. The impact of prenatal vitamin A and zinc supplementation on growth of children up to 2 years of age in rural Java, Indonesia. Public Health Nutr. 2011;14(12):2197–206.PubMed

23.

Rerksuppaphol S, Rerksuppaphol L. Effect of zinc plus multivitamin supplementation on growth in school children. Pediatr Int. 2016;58(11):1193–9.PubMed

24.

Soofi S, Cousens S, Iqbal SP, Akhund T, Khan J, Ahmed I, Zaidi AK, Bhutta ZA. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet. 2013;382(9886):29–40.PubMed

25.

Troesch B, van Stuijvenberg ME, Smuts CM, Kruger HS, Biebinger R, Hurrell RF, Baumgartner J, Zimmermann MB. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight-for-age Z-scores in south african children. J Nutr. 2011;141(2):237–42.PubMed

26.

Barffour MA, Hinnouho GM, Kounnavong S, Wessells KR, Ratsavong K, Bounheuang B, Chanhthavong B, Sitthideth D, Sengnam K, Arnold CD, et al. Effects of Daily Zinc, Daily multiple micronutrient powder, or therapeutic zinc supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in rural laotian children: a Randomized Controlled Trial. J Pediatr. 2019;207:80–89e82.PubMedPubMedCentral

27.

Lebenthal Y, Yackobovitch-Gavan M, Lazar L, Shalitin S, Tenenbaum A, Shamir R, Phillip M. Effect of a nutritional supplement on growth in short and lean prepubertal children: a prospective, randomized, double-blind, placebo-controlled study. J Pediatr. 2014;165(6):1190–1193e1191.PubMed

28.

Lopes MMGD, De Brito NJN, De Medeiros Rocha ÉD, França MC, De Das Graças M, Brandão-Neto J. Nutritional assessment methods for zinc supplementation in prepubertal non-zinc-deficient children. Food and Nutrition Research 2015, 59.

29.

Effect of provision. Of micronutrient supplementation on growth and morbidity among young children in Pakistan. Arch Dis Child. 2013;98(9):691.

30.

Abdollahi M, Abdollahi Z, Fozouni F, Bondarianzadeh D. Oral zinc supplementation positively affects linear growth, but not weight, in children 6–24 months of age. Int J Prev Med. 2014;5(3):280–6.PubMedPubMedCentral

31.

Abdollahi M, Ajami M, Abdollahi Z, Kalantari N, Houshiarrad A, Fozouni F, Fallahrokni A, Mazandarani FS. Zinc supplementation is an effective and feasible strategy to prevent growth retardation in 6 to 24 month children: a pragmatic double blind, randomized trial. Heliyon. 2019;5(11):e02581.PubMedPubMedCentral

32.

Batool N, Shaikh S, Chohan MN. Clinical effectiveness of prophylactic zinc on growth, pneumonia and diarrhea in children less than 1 year. J Liaquat Univ Med Health Sci. 2021;20(1):26–30.

33.

Locks LM, Manji KP, McDonald CM, Kupka R, Kisenge R, Aboud S, Wang M, Fawzi WW, Duggan CP. Effect of zinc and multivitamin supplementation on the growth of Tanzanian children aged 6–84 wk: a randomized, placebo-controlled, double-blind trial. Am J Clin Nutr. 2016;103(3):910–8.PubMedPubMedCentral

34.

Adu-Afarwuah S, Lartey A, Okronipa H, Ashorn P, Peerson JM, Arimond M, Ashorn U, Zeilani M, Vosti S, Dewey KG. Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial. Am J Clin Nutr. 2016;104(3):797–808.PubMedPubMedCentral

35.

Vakili R, Yazdan Bakhsh M, Vahedian M, Mahmoudi M, Saeidi M, Vakili S. The effect of zinc supplementation on linear growth and growth factors in primary schoolchildren in the suburbs mashhad, iran. Int J Pediatr. 2015;3(21):1–7.

36.

Rerksuppaphol S, Rerksuppaphol L. Zinc supplementation enhances linear growth in school-aged children: a randomized controlled trial. Pediatr Rep. 2017;9(4):58–63.

37.

Ruz M, Castillo-Duran C, Lara X, Codoceo J, Rebolledo A, Atalah E. A 14-mo zinc-supplementation trial in apparently healthy chilean preschool children. Am J Clin Nutr. 1997;66(6):1406–13.PubMed

38.

Clark PJ, Eastell R, Barker ME. Zinc supplementation and bone growth in pubertal girls. The Lancet. 1999;354(9177):485.

39.

Kaseb F, Fallah R. Efficacy of zinc supplementation on improvement of weight and height growth of healthy 9–18 year children. World Appl Sci J. 2013;26:89–93.

40.

Kikafunda JK, Walker AF, Allan EF, Tumwine JK. Effect of zinc supplementation on growth and body composition of ugandan preschool children: a randomized, controlled, intervention trial. Am J Clin Nutr. 1998;68(6):1261–6.PubMed

41.

Ebrahimi S, Pormahmodi A, Kamkar A. Study of zinc supplementation on growth of schoolchildren in Yasuj, Southwest of Iran. Pak J Nutr. 2006;5(4):341–2.

42.

Dehbozorgi P, Mohseni P, Mazloom Z. The influence of zinc sulfate on the growth of school age children in villages around Shiraz 2002, 2003. J Med Sci. 2007;7(4):690–3.

43.

Vakili R, Bakhsh MY, Vahedian M, Mahmoudi M, Saeidi M, Vakili S. The effect of zinc supplementation on linear growth and growth factors in primary schoolchildren in the suburbs Mashhad, Iran. Int J Pediatr. 2015;3(2):1–7.

44.

children. : improving survival and well-being [https://www.who.int/news-room/fact-sheets/detail/children-reducing-mortality]

45.

Kapil U, Jain K. Magnitude of zinc deficiency amongst under five children in India. Indian J Pediatr. 2011;78(9):1069–72.PubMed

46.

Ramakrishnan U, Nguyen P, Martorell R. Effects of micronutrients on growth of children under 5 y of age: meta-analyses of single and multiple nutrient interventions. Am J Clin Nutr. 2009;89(1):191–203.PubMed

47.

Alves CX, Vale SHL, Dantas MMG, Maia AA, Franca MC, Marchini JS, Leite LD, Brandao-Neto J. Positive effects of zinc supplementation on growth, GH, IGF1, and IGFBP3 in eutrophic children. J Pediatr Endocrinol Metab. 2012;25(9–10):881–7.PubMed

48.

Sun P, Wang S, Jiang Y, Tao Y, Tian Y, Zhu K, Wan H, Zhang L, Zhang L. Zip1, Zip2, and Zip8 mRNA expressions were associated with growth hormone level during the growth hormone provocation test in children with short stature. Biol Trace Elem Res. 2013;155(1):11–22.PubMed

49.

Oner G, Bhaumick B, Bala RM. Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology. 1984;114(5):1860–3.PubMed

50.

Herington A. Effect of zinc on the binding and action of growth hormone in isolated rat adipocytes. Biochem Int. 1985;11(6):853–62.PubMed

51.

Lefebvre D, Beckers F, Ketelslegers J-M, Thissen J-P. Zinc regulation of insulin-like growth factor-I (IGF-I), growth hormone receptor (GHR) and binding protein (GHBP) gene expression in rat cultured hepatocytes. Mol Cell Endocrinol. 1998;138(1–2):127–36.PubMed

52.

Cesur Y, Yordam N, Doğan M. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with zinc deficiency and the effect of zinc supplementation on these parameters. J Pediatr Endocrinol Metab. 2009;22(12):1137–44.PubMed

53.

Pompano LM, Boy E. Effects of dose and duration of zinc interventions on risk factors for type 2 diabetes and cardiovascular disease: a systematic review and meta-analysis. Adv Nutr. 2021;12(1):141–60.PubMed

54.

Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Gender differences in the relationship between serum zinc concentration and metabolic syndrome. Ann Hum Biol. 2014;41(5):436–42.PubMed

55.

Larson CP, Roy S, Khan AI, Rahman AS, Qadri F. Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease. J Health Popul Nutr. 2008;26(3):356.PubMedPubMedCentral

56.

IntHout J, Ioannidis JP, Borm GF, Goeman JJ. Small studies are more heterogeneous than large ones: a meta-meta-analysis. J Clin Epidemiol. 2015;68(8):860–9.PubMed

Titel: The effect of zinc supplementation on anthropometric measurements in healthy children over two years: a systematic review and meta-analysis
verfasst von: Vahid Monfared
Adel Salehian
Zeinab Nikniaz
Soraiya Ebrahimpour-Koujan
Zeinab Faghfoori
Publikationsdatum: 01.12.2023
Verlag: BioMed Central
Erschienen in: BMC Pediatrics / Ausgabe 1/2023
Elektronische ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-023-04249-x

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Supplementary Information

Publisher’s Note

Background

Materials and methods

Search strategy

Inclusion criteria

Data extraction

Risk of bias assessment

Certainty assessment

Statistical analysis

Results

Study selection

Study characteristics

Risk of bias result

Grading of evidence

Findings from the meta-analysis

The effect of zinc supplementation on weight

The effect of zinc supplementation on height

The effect of zinc supplementation on WAZ

The effect of zinc supplementation on HAZ

Sensitivity analysis

Publication bias

Meta-regression analysis

Discussion

Limitations

Conclusion

Acknowledgements

Declarations

Ethics approval and consent to participate

Consent for publication

Competing interests

Publisher’s Note

Electronic supplementary material

Weitere Artikel der Ausgabe 1/2023

The genotypic and phenotypic characteristics contributing to high virulence and antibiotics resistance in Escherichia coli O25-B2-ST131 in comparison to non- O25-B2-ST131

Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis

Correction: Current situation and influencing factors of Disease uncertainty in parents of children with Sturge‒Weber syndrome: a retrospective study

Eating behaviour, quality of life and cardiovascular risk in obese and overweight children and adolescents: a cross-sectional study

White-Sutton syndrome and congenital heart disease: case report and literature review

Risk factors for postoperative complications following one-stage proximal hypospadias repair involving the disconnection of the urethral plate: a retrospective study

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie